These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 7230045

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B, Ottesen B, Fahrenkrug J, Fuchs AR.
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [Abstract] [Full Text] [Related]

  • 23. Nervous release of vasoactive intestinal polypeptide from the feline uterus: pharmacological characteristics.
    Fahrenkrug J, Ottesen B.
    J Physiol; 1982 Oct; 331():451-60. PubMed ID: 7153911
    [Abstract] [Full Text] [Related]

  • 24. Effects of autonomic stimulation on the release of vasoactive intestinal peptide from the gastrointestinal tract in the calf.
    Bloom SR, Edwards AV.
    J Physiol; 1980 Feb; 299():437-52. PubMed ID: 6991667
    [Abstract] [Full Text] [Related]

  • 25. Vasoactive intestinal polypeptide and the female genital tract: relationship to reproductive phase and delivery.
    Ottesen B, Ulrichsen H, Fahrenkrug J, Larsen JJ, Wagner G, Schierup L, Søndergaard F.
    Am J Obstet Gynecol; 1982 Jun 15; 143(4):414-20. PubMed ID: 7201240
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat.
    Nilsson SF, Mäepea O.
    Acta Physiol Scand; 1987 Jan 15; 129(1):17-26. PubMed ID: 3565040
    [Abstract] [Full Text] [Related]

  • 27. Vasoactive intestinal polypeptide (VIP): effects in the eye and on regional blood flows.
    Nilsson SF, Bill A.
    Acta Physiol Scand; 1984 Aug 15; 121(4):385-92. PubMed ID: 6148840
    [Abstract] [Full Text] [Related]

  • 28. Effects of vasoactive intestinal polypeptide on renal function in man.
    Calam J, Dimaline R, Peart WS, Singh J, Unwin RJ.
    J Physiol; 1983 Dec 15; 345():469-75. PubMed ID: 6363677
    [Abstract] [Full Text] [Related]

  • 29. Vasoactive intestinal polypeptide and the canine cerebral circulation.
    Wilson DA, O'Neill JT, Said SI, Traystman RJ.
    Circ Res; 1981 Jan 15; 48(1):138-48. PubMed ID: 7438343
    [Abstract] [Full Text] [Related]

  • 30. VIP and its homologues increase vascular conductance in certain endocrine and exocrine glands.
    Huffman LJ, Connors JM, Hedge GA.
    Am J Physiol; 1988 Apr 15; 254(4 Pt 1):E435-42. PubMed ID: 3354661
    [Abstract] [Full Text] [Related]

  • 31. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion.
    Lundberg JM, Anggård A, Fahrenkrug J.
    Acta Physiol Scand; 1982 Mar 15; 114(3):329-37. PubMed ID: 6182751
    [Abstract] [Full Text] [Related]

  • 32. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow.
    Feliciano L, Henning RJ.
    Cardiovasc Res; 1998 Oct 15; 40(1):45-55. PubMed ID: 9876316
    [Abstract] [Full Text] [Related]

  • 33. Effects of vasoactive intestinal peptide (VIP) on the testicular vasculature of the rat.
    Lissbrant E, Bergh A.
    Int J Androl; 1997 Dec 15; 20(6):356-60. PubMed ID: 9568528
    [Abstract] [Full Text] [Related]

  • 34. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B.
    Acta Physiol Scand; 1981 Oct 15; 113(2):193-9. PubMed ID: 6947684
    [Abstract] [Full Text] [Related]

  • 35. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
    Gardiner SM, Rakhit T, Kemp PA, March JE, Bennett T.
    Br J Pharmacol; 1994 Feb 15; 111(2):589-97. PubMed ID: 7911721
    [Abstract] [Full Text] [Related]

  • 36. Effect of vasoactive intestinal polypeptide (VIP) on the in vitro and in vivo motility of the rabbit reproductive tract.
    Fredericks CM, Ashton SH.
    Fertil Steril; 1982 Jun 15; 37(6):845-50. PubMed ID: 7084506
    [Abstract] [Full Text] [Related]

  • 37. Immunohistochemical localization and vascular effects of vasoactive intestinal polypeptide in skeletal muscle of the cat.
    Järhult J, Hellstrand P, Sundler F.
    Cell Tissue Res; 1980 Jun 15; 207(1):55-64. PubMed ID: 7388912
    [Abstract] [Full Text] [Related]

  • 38. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery.
    Jovanović A, Jovanović S, Tulić I, Grbović L.
    Mol Hum Reprod; 1998 Jan 15; 4(1):71-6. PubMed ID: 9510014
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of action of vasoactive intestinal polypeptide on myometrial smooth muscle of rabbit and guinea-pig.
    Bolton TB, Lang RJ, Ottesen B.
    J Physiol; 1981 Sep 15; 318():41-55. PubMed ID: 7320897
    [Abstract] [Full Text] [Related]

  • 40. Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine.
    Shimizu T, Taira N.
    Br J Pharmacol; 1979 Apr 15; 65(4):683-7. PubMed ID: 435691
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.